← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Adepthera, Llc
Palo Alto, CA
$2,850,322
Total funding
10
Grants
Funding over time
peak $587.4K · FY2014–24$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,850,322 · 10
By mechanism
R43$2,401,646 · 8
R41$448,676 · 2
Investigators at Adepthera, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Regenerative peptide therapy to accelerate pressure ulcer healing$367,577
R43 · FY2024 · AG
Development of a treatment-resistant hypertension (RHTN) depot therapeutics$338,152
R43 · FY2019 · HL
A therapy for improving diabetic ulcer healing$335,342
R43 · FY2023 · DK
A hormonal therapy for bronchopulmonary dysplasia$299,299
R43 · FY2015 · HL
Novel Nanomedicine for Treatment-resistant Hypertension (RHTN)$296,941
R43 · FY2017 · HL
Novel Therapeutics for Endothelial Dysfunction$290,425
R43 · FY2017 · TR
Development of a novel anti-migraine therapeutics$248,910
R43 · FY2019 · NS
Developing Novel Therapies for Treating Breast-Cancer-Related Lymphedema$225,000
R41 · FY2014 · CA
Prevention of Preeclampsia-associated preterm births$225,000
R43 · FY2014 · HD
A hormonal therapy for preeclampsia$223,676
R41 · FY2015 · HD